The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IWWM-11 2022 | The aims and projects of the Leukemia & Lymphoma society
Lee Greenberger, PhD, Leukemia & Lymphoma Society, New York, NY, highlights the aims and projects of the Leukemia & Lymphoma Society, which aims to obtain cures for hematological malignancies and improve patients’ access to therapeutic agents. Following this, Dr Greenberger describes current challenges with preserving antibody responses against COVID-19 in patients with Waldenström’s macroglobulinemia (WM) treated with Bruton’s tyrosine kinase (BTK) inhibitors and antibodies. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
